Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Study on the concentration, distribution, and persistence of health spending for the contributory scheme in Colombia.

Espinosa O. et al, (2024), BMC Health Serv Res, 24

Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron.

Paternina-Caicedo A. et al, (2024), J Infect

Comparative effectiveness and duration of protection of ChAdOx1, CoronaVac, BNT162b2, mRNA-1273, and Ad26.COV2.S COVID-19 vaccines for symptomatic and hospitalized Mu, Delta, and Omicron: A test-negative case-control study.

Paternina-Caicedo A. et al, (2023), Vaccine

Reductions in Childhood Pneumonia Mortality After Vaccination in the United States

Paternina-Caicedo A. et al, (2023), The Pediatric Infectious Disease Journal

Social interventions can lower COVID-19 deaths in middle-income countries

Paternina-Caicedo A. et al, (2020)

Include forthcoming?